Frontiers in immunology , 10 , 245
Abid, M
93,94,95,96 Advancements in carrier technology and nucleic acid modification techniques have led to significant progress in overcoming these challenges, as exemplified by the first siRNA drug, patisiran (Onpattro), which has been approved for treating hereditary transthyretin-mediated amyloidosis by degrading mRNA encoding transthyretin (TTR)
The ROC curve features identified using PLS-DA and cross-validation (CV) exhibited area under the curve (AUC) values ranging from 0.95 to 0.996, with confidence intervals (CI) of 0.818-1 and 0.975-1, respectively (Fig
Effective and Nourishing Ingredients: Formulated with glutathione, nicotinamide, hyaluronic acid, and arbutin, the lotion deeply moisturizes, improves elasticity, provides a protective barrier, and helps brighten and even out skin tone
Call to Action